Martyn Davies
Presidente en The University of Nottingham .
Perfil
Martyn Davies is currently the Chairman at The University of Nottingham and the Secretary at The Controlled Release Society.
He was previously a Non-Executive Director at Critical Pharmaceuticals Ltd.
Cargos activos de Martyn Davies
Empresas | Cargo | Inicio |
---|---|---|
The University of Nottingham | Presidente | - |
The Controlled Release Society
The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Secretario Corporativo | - |
Antiguos cargos conocidos de Martyn Davies.
Empresas | Cargo | Fin |
---|---|---|
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
The Controlled Release Society
The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Commercial Services |
Critical Pharmaceuticals Ltd.
Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Martyn Davies